/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | AHCOAdaptHealth Corp. |
|---|---|
| Last close | $6.28close 2026-11-03 |
| Change % | +6.26%close 2026-11-03 |
| Market cap | $857Mclose 2026-11-03 |
| P/E | loss, no P/E |
| Revenue | $3.2B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-011213 · filed 2026-02-24 Open the filing on EDGAR → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -0.5%FY to 2025-12-31 |
| Net income | $-70794000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-011213 · filed 2026-02-24 Open the filing on EDGAR →Open the XBRL payload →CiteAdaptHealth Corp. (AHCO), us-gaap:NetIncomeLoss: -70,794,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-011213, filed 2026-02-24. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001725255/us-gaap/NetIncomeLoss.json |
| Net margin | -2.2%FY to 2025-12-31 |
| EPS (diluted) | $-0.52⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-011213 · filed 2026-02-24 Open the filing on EDGAR →Open the XBRL payload →CiteAdaptHealth Corp. (AHCO), us-gaap:EarningsPerShareDiluted: -0.52 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-011213, filed 2026-02-24. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001725255/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 5FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | 0.80FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 02-18 → 02-28 |